RN Levy
Impact in
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.5%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 5
- Chronic Lymphocytic Leukemia Research 4
- Myeloproliferative Neoplasms: Diagnosis and Treatment 1
-
- Acute Lymphoblastic Leukemia research 4
- Co-authors
- A. D. Chanana (2 shared papers)Cronkite Ep (2 shared papers)KR Rai (2 shared papers)Harvey D. Preisler (1 shared paper)RB Davis (1 shared paper)Robert W. Carey (1 shared paper)Philip Schulman (1 shared paper)Fred Richards (1 shared paper)
- Journals
- Blood (4 papers)PubMed (3 papers)
- Partner nations
- United States
In The Last Decade
RN Levy
7 papers receiving 2.4k citations
RN Levy's Hit Papers
Peers
Comparison fields: 5 of 61
- Genetics 2.2k
- Pathology and Forensic Medicine 1.4k
- Immunology 1.0k
- Hematology 481
- Gastroenterology 57
Countries citing papers authored by RN Levy
This map shows the geographic impact of RN Levy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RN Levy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RN Levy more than expected).
Fields of papers citing papers by RN Levy
This network shows the impact of papers produced by RN Levy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RN Levy. The network helps show where RN Levy may publish in the future.
Co-authors
The 25 scholars most cited alongside RN Levy, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical staging of chronic lymphocytic leukemia Hit paper breakdown → | 1975 | 2066 |
| 2 | 1975 | 226 | |
| 3 | 1987 | 225 | |
| 4 | 1984 | 8 | |
| 5 | Daunorubicin (NSC-83142) versus daunorubicin plus prednisone (NSC-10023) versus daunorubicin plus vincristine (NSC-67574) plus prednisone in advanced childhood acute lymphocytic leukemia. | 1972 | 6 |
| 6 | Therapy of polycythemia vera with radiotytrium (Y-90). | 1962 | 5 |
| 7 | Intermittent therapy with 6-mercaptopurine (NSC-755) and methotrexate (NSC-740) given intravenously to adults with acute leukemia. | 1972 | 3 |
About RN Levy
RN Levy is a scholar working on Genetics, Public Health, Environmental and Occupational Health, Oncology, Hematology and Pathology and Forensic Medicine, having authored 7 papers that have together received 2.5k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (4 papers), Acute Lymphoblastic Leukemia research (4 papers), Acute Myeloid Leukemia Research (2 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper), Childhood Cancer Survivors' Quality of Life (1 paper), Eosinophilic Disorders and Syndromes (1 paper), Polyomavirus and related diseases (1 paper) and Neutropenia and Cancer Infections (1 paper). The work is most often cited by research in Genetics (2.2k citations), Pathology and Forensic Medicine (1.4k citations), Immunology (1.0k citations), Hematology (481 citations) and Gastroenterology (57 citations). RN Levy has collaborated with scholars based in United States. Frequent co-authors include A. D. Chanana, Cronkite Ep, KR Rai, Harvey D. Preisler, RB Davis, Robert W. Carey, Philip Schulman, Fred Richards, Jeffrey J. Kirshner and Samuel Kopel. Their work appears in journals such as Blood and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.